China Ever Grand Financial Leasing Group Co., Ltd. operates as an investment holding entity, delivering a broad spectrum of services primarily within the People's Republic of China and Hong Kong. The company's diverse operations are organized across several key divisions, encompassing financial services, investment activities, trading, and manufacturing. Its financial leasing segment is dedicated to offering finance lease advisory and funding solutions. The investment arm manages a portfolio of properties and securities, alongside engaging in money lending. Through its trading division, the company handles the distribution and sale of essential items such as medical, health, and hygiene products, as well as general daily necessities. Furthermore, the manufacturing segment focuses on the research, development, production, and sale of food additives, novel food ingredients, and nutritional supplements. Recently, in September 2025, the company announced a significant strategic move, terminating an earlier agreement for the disposal of Property 103 and entering into a new arrangement with Solarbio for the same asset. This transaction, classified as substantial, is subject to shareholder approval. Established in 2002, the company was previously known as PME Group Limited before adopting its current name in February 2016. China Ever Grand Financial Leasing Group Co., Ltd. maintains its principal offices in Wan Chai, Hong Kong.